British Columbia, Canada
http://www.flustop.ca

Trinity Healthy Living Products Inc is a global distribution company currently marketing and selling 2 main products. FluSTOP, an all natural anti-viral spray to the back of the throat. BNEC[BRAIN & NERVE ENHANCEMENT COMPOUND] is an all natural product that has had a 50-100% effectiveness rate on ALS, Autism, MS, Parkinsons and more neurological diseases.

Manufacturing is contracted out and the product is sold globally out of the North American office. Research is ongoing with the founding inventors with colaberation being developed at various universities. Last years thrust was retail and this year the company is venturing into a very defined market segment untouched by any of its competitors. After the product is established in this segment it will go after 3 other identified markets.

FluSTOP There is no other product which has been clinical proven to inactivate influenza A & B virus on contact with no side affects. The product is unique because the herb combination reacts with what is common to all influenza strains, the Haemmagluttinen or HA of all viruses. Summary 1. The only all natural product on the market that interacts directly with viruses and inactivates them on contact. 2. Clinically proven to be 75% effective in two days and 83% effective in three days. 3. No known side affects as per anti-virals, cost effective, no need to re-manufacture according to strains as per flu shots, able to give to young children and no known drug resistance. There are four sectors that FluSTOP competes in, namely, flu vaccines, FluMist, antiviral drugs and other natural health products. Traditional vaccines must be updated yearly creating a very short time frame to produce and deliver and don’t cover all strains. Furthermore, there is significant evidence to show that flu vaccine results are questionable and may even pose health risks. FluMist is priced high, stored frozen and restricted to healthy individuals. Anti-virals work only with type A influenza, have adverse effects, are unsafe for children and create drug resistance. Natural products need not have an approval process to demonstrate their safety and effectiveness, thus eroding consumer confidence. Trinity has a duel marketing strategy. It will continue to sell based on the pre-clinical evidence it has gathered in order to gain market share. However, the significantly larger potential to market will occur once full clinical trials are completed. Trinity will then have the capability to rise above the typical unproven natural products category. Trinity is creating a hybrid model whereby health professionals and the naturopathic community will endorse the product. Efficacy, safety, low production costs, ease of application and global rights to a proprietary formula are the main advantages. BRAIN & NERVE ENHANCEMENT COMPOUND There are no other products marketed which have clinical trials proving 50-100% effectiveness rates on ALS, Autism, Parkinsons, etc. The opportunity is phenominal.

Both products have clinical trial backing. One product has an established IP and the other is in process. More clinicals need to be completed for increased confidence.

President: Greg Gerrie has degrees in Economics and Education from Queen’s University and is trained in leadership from the Canadian Armed Forces Officer Training Program. As a Training and Development specialist, Greg has worked for the University of Toronto, was head of Business Education and Career and Personal Planning at two private schools, worked for the Open Learning Agency as a Training Needs Analysis consultant and has taught programs in Management, Leadership and Motivation in the United Kingdom, Singapore, Canada, USA and India. Greg is author of the book Fired UP For Life. This book is the culmination of three years of research in the realm of success and motivation and has gained international interest. In the past five years, Greg has been involved in business development in three firms in the realm of immigration, medical equipment sales, real-estate development and a national fitness program taking him to India and Dubai as well as engaging domestic markets. Head of Science & Co-Founder: Professor D.S. Liu, PhD, is one of China's leading viral scientists and medical doctors. He is the inventor of Flu-STOP™ has 40+ years of study and teaching in the field of molecular biology. He is a medical doctor graduate from China's prestigious China Medical University and then went on to do a post-graduate degree at the China Academy of Medical Sciences. Professor Liu is a scientific advisor for anti-cancer drug development at Swiss Debiopharm Research Foundation. He has been honoured with the National Special Contribution Scientist Award by the State Council of China and is a member of the editorial committee of the China Immunology Journal and the China Biological Products Journal. Note: Trinity is currently courting a noted virologist who works with UBC. VP Operations & Co-Founder: Xinglin Liu has sales and marketing experience in England, Italy, China and the USA in the pharmaceutical industry. He is also an expert in every aspect of operations from bringing the product from its raw material state, to sterile manufacturing processes to landing product in Canada. Informal Board While Trinity has yet to formalize its Board, it has the privilege of many advisors who are “coaching” the current CEO. Paul Stinson, former head of BC Biotech has been instrumental in forward movement. Wei Du and expert in China-Canada business relations. Roger Killen has assisted with investor’s strategy.

2 key Board members who are industry experts and who have been there before.